Forward Pharma As (FWP) SEC Filing 20-F Annual report for the fiscal year ending Saturday, December 31, 2016

Forward Pharma As

CIK: 1604924 Ticker: FWP

View differences made from one year to another to evaluate Forward Pharma As's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Forward Pharma As.


Assess how Forward Pharma As's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Forward Pharma As's Definitive Proxy Statement (Form DEF 14A) filed after their 2017 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: FWP
CIK: 1604924
Form Type: 20-F Annual Report
Accession Number: 0001047469-17-002703
Submitted to the SEC: Tue Apr 18 2017 5:21:27 PM EST
Accepted by the SEC: Tue Apr 18 2017
Period: Saturday, December 31, 2016
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: